Choo Chee Kong ownership in CytoMed Therapeutics Ltd Ordinary Shares, no par value per share (GDTC)
2025-03-14 - Choo Chee Kong has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.67M shares of CytoMed Therapeutics Ltd Ordinary Shares, no par value per share (GDTC).
This represents 23.2% percent ownership of the company.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.